Investigation of patient-derived endometriosis in a 3D-in-vivo-model

In: Geburtshilfe und Frauenheilkunde · 2024 · vol. 84(10) , pp. e220 · doi:10.1055/s-0044-1790966 · W4403327702
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-07-26

This study investigated patient-derived endometriosis using a 3D-in-vivo model to explore its behavior and characteristics in a simulated environment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Full text 1,905 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Material

The chorioallantoic membrane (CAM) model was used to establish a 3D-in-vivo-model for the investigation of endometriosis. Endometriosis tissue was obtained from patients undergoing surgery at an EndoCert certified hospital.

Methods

Changes in the vascularization of the engrafted tissue on the CAM were measured over time using laser speckle contrast analysis (LASCA). The fertilized chicken eggs used for the CAM model were stratified for their gender utilizing an in ovo sexing technique. To test for changes of molecular markers throughout the engraftment period, immunohistochemical staining was performed. Patient-related data was analyzed in retrospect using the AGEM questionnaire.

Results

Preliminary data show an increase in vascularization of the engrafted tissue on the CAM. The analysis of Ki67 shows proliferative activity of endometriosis cells at the end of the experiment. The comparative results between laboratory and clinical data and the effect of chicken estrogen on the investigated endometriosis tissue are under current investigation. Summary: Angiogenesis as one of the major pathologic features of endometriosis can be measured in the 3D-in-vivo-model via an increase in vascularization. As the patient-derived tissue remained vital the model can potentially be used for the testing of drugs and their effect on proliferation, angiogenesis, and molecular markers, amongst others. Publication History Article published online: 01 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-22T06:23:50.750314+00:00
License: CC0 · commercial use OK